Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 22, 2021
Reporting Period: Specific event date (July 22, 2021)
cbdMD, Inc., an emerging growth company incorporated in North Carolina, reported the completion of an asset acquisition and a key executive appointment on July 22, 2021.
Key Financial Metrics and Transaction Details
This filing details a specific transaction rather than periodic financial results. Key financial terms include:
- Acquisition Consideration: Total consideration of $2,000,000 cash plus up to 600,000 shares of restricted common stock.
- Cash Payment Structure: $1,800,000 paid at closing; $200,000 held in escrow for post-closing adjustments and indemnity.
- Stock Issuance Structure:
- 300,000 shares issued at closing.
- 100,000 shares to be issued by January 31, 2023 (subject to indemnity setoffs).
- 200,000 shares to be issued within 60 days of the first anniversary of closing (subject to earn-out provisions).
- Executive Compensation: New Chief Revenue Officer appointed with a base salary of $180,000, a discretionary bonus up to 40% of base, and a one-time performance bonus of $160,000 contingent on quarterly net sales exceeding $16,000,000 prior to September 30, 2022.
Note: The filing does not provide general revenue, profit, cash flow, margin, debt, or liquidity metrics for the company as a whole.
Material Changes
The primary material change is the expansion of the company's business through the acquisition of the DirectCBDOnline.com online marketplace. The Company acquired related trademarks, inventory, and certain other assets while assuming specific liabilities. Additionally, the company's executive leadership was expanded with the appointment of a new Chief Revenue Officer.
Outlook, Risks, and Unusual Items
- Strategic Outlook: The acquisition of DirectCBDOnline.com is intended to provide CBD education and a selection of high-quality CBD products (oils, tinctures, salves, capsules, gummies).
- Performance Contingencies: A significant portion of the acquisition consideration (200,000 shares) and the new executive's bonus ($160,000) are contingent on future performance metrics (earn-outs and sales targets).
- Lock-Up Provisions: The 600,000 shares issued to the seller are subject to a 180-day lock-up agreement with limited transfer exceptions.
- Risks: The filing notes that the stock issuance was exempt from registration under Section 4(a)(2) of the Securities Act of 1933. The employment agreement includes standard termination clauses for cause, death, or disability.
Investor Verification Checklist
- Verify the exact terms of the earn-out provisions for the remaining 200,000 shares in the Asset Purchase Agreement (Exhibit 10.1).
- Confirm the specific liabilities assumed from the Seller as part of the DirectCBDOnline.com acquisition.
- Monitor the company's quarterly net sales to determine if the $16,000,000 threshold for the new CRO's performance bonus is met before September 30, 2022.
- Review the escrow agreement details regarding the $200,000 held for indemnity claims.